Target intelligence / Profile preview

Epsin-3 (EPN3)

Target
EPN3
Molecular classification
Endocytic adaptor protein, Membrane-associated protein, Other
01

Overview

Epsin-3 is a member of the epsin family of highly conserved membrane-associated endocytic adaptor proteins. It is characterized by an N-terminal ENTH (Epsin N-Terminal Homology) domain that binds phosphatidylinositol (4,5)-bisphosphate and contributes to the initiation of clathrin-coated vesicle formation through membrane curvature induction. Unlike other epsins, Epsin-3 displays highly regulated expression and is induced in human keratinocytes migrating over type I collagen, such as during cutaneous wound healing; it is not detectable in healthy, differentiated skin. Epsin-3 is implicated in the coordination of endocytosis and signal transduction, acting as an adaptor that helps recruit ubiquitinated cargo to the clathrin-mediated endocytic machinery and interacts with Rho GTPase-regulatory proteins, linking cell signaling and polarity with membrane trafficking. Upregulation of Epsin-3 has been observed in epithelial pathologies and several cancer types, where it is thought to enhance cell migration and invasion, making it a candidate biomarker and a potential therapeutic target in oncology. Currently, no direct drug interactions or approved targeted therapies are known for Epsin-3.

Other names
EPN3FLJ20778MGC129899EPS-15-interacting protein 3epsin-3
02

Biological functions

EndocytosisClathrin-mediated vesicle formationRegulation of cell migrationCell polaritySignal transduction (Notch and Rho GTPase pathways)
03

Disease associations

Cancer (notably skin, breast, lung, and pancreatic cancer)Wound healing/pathological epithelial migrationOther (possible involvement in Adult Spinal Cord Ependymoma)
04

Safety considerations

Upregulation may promote cancer cell migration and invasion
05

Biomarkers

Overexpression in certain epithelial cancers (potential prognostic marker)Induced expression in migrating keratinocytes during wound healing

Beyond the preview

Go deeper on Epsin-3 (EPN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epsin-3 (EPN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call